Barrow, Hanley, Mewhinney & Strauss’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,212,856
Closed -$1.71M 342
2022
Q1
$1.71M Sell
1,212,856
-35,169
-3% -$75.2K 0.01% 144
2021
Q4
$3.4M Sell
1,248,025
-34,466
-3% -$127K 0.01% 151
2021
Q3
$6.1M Sell
1,282,491
-14,696
-1% -$107K 0.02% 141
2021
Q2
$10.5M Sell
1,297,187
-94,423
-7% -$786K 0.03% 135
2021
Q1
$11.2M Sell
1,391,610
-168,067
-11% -$1.57M 0.04% 136
2020
Q4
$14M Sell
1,559,677
-275,754
-15% -$2.29M 0.05% 131
2020
Q3
$13.8M Sell
1,835,431
-7,331
-0.4% -$50.8K 0.05% 133
2020
Q2
$11.7M Sell
1,842,762
-261,201
-12% -$1.75M 0.05% 130
2020
Q1
$15.6M Buy
2,103,963
+41,654
+2% +$323K 0.07% 113
2019
Q4
$18.6M Buy
2,062,309
+12,757
+0.6% +$107K 0.06% 121
2019
Q3
$15.4M Sell
2,049,552
-175,358
-8% -$984K 0.03% 137
2019
Q2
$11.5M Sell
2,224,910
-197,421
-8% -$1.29M 0.02% 142
2019
Q1
$20.3M Buy
2,422,331
+286,243
+13% +$2.06M 0.04% 144
2018
Q4
$9.19M Sell
2,136,088
-28,381
-1% -$251K 0.02% 150
2018
Q3
$31.5M Sell
2,164,469
-19,563
-0.9% -$324K 0.05% 148
2018
Q2
$40.6M Sell
2,184,032
-155,527
-7% -$2.81M 0.07% 148
2018
Q1
$40.7M Sell
2,339,559
-19,793
-0.8% -$349K 0.06% 144
2017
Q4
$39.8M Sell
2,359,352
-23,870
-1% -$388K 0.06% 143
2017
Q3
$37.5M Buy
2,383,222
+2,067,186
+654% +$29.5M 0.06% 145
2017
Q2
$4.17M Hold
316,036
0.01% 230
2017
Q1
$3.76M Buy
316,036
+10,687
+3% +$128K 0.01% 236
2016
Q4
$3.98M Buy
305,349
+36,267
+13% +$417K 0.01% 229
2016
Q3
$3.01M Buy
269,082
+14,954
+6% +$180K ﹤0.01% 233
2016
Q2
$3.08M Buy
254,128
+46,592
+22% +$549K ﹤0.01% 225
2016
Q1
$2.73M Buy
+207,536
New +$2.94M ﹤0.01% 226

Other funds holding IVC

Barrow, Hanley, Mewhinney & Strauss's IVC Position: Q2 2022 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Invacare Corporation (IVC) in Q2 2022, closing a stake of 1,212,856 shares — an estimated $1.71M sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in IVC in Q1 2016 and held it in 25 quarters. The position peaked at $40.7M in Q1 2018. 83 funds tracked by Wall St. Rank hold IVC as of Q2 2022.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Invacare Corporation position as of Q2 2022 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 1,212,856 Invacare Corporation shares in Q2 2022, an estimated $1.71M.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Invacare Corporation in Q1 2016 and held it in 25 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Invacare Corporation position peaked at $40.7M in Q1 2018.
  • 83 funds tracked by Wall St. Rank held Invacare Corporation as of Q2 2022.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2022, filed 11 Aug 2022.